<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>At present there are nearly 3 million people with <z:mp ids='MP_0002055'>diabetes</z:mp> in the UK </plain></SENT>
<SENT sid="1" pm="."><plain>It is predicted that this number will almost double by 2025 </plain></SENT>
<SENT sid="2" pm="."><plain>Nine out of ten of these individuals will have type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>It is estimated that one in seven adults have impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> regulation and up to 12% of these will develop type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> each year </plain></SENT>
<SENT sid="4" pm="."><plain>The impact of <z:hpo ids='HP_0001513'>obesity</z:hpo> on the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> cannot be overemphasised, with a 1 kg/m2 increase in BMI raising the risk of impaired fasting glycaemia by 9.5% and of developing new-<z:hpo ids='HP_0003674'>onset</z:hpo> type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> by 8.4% </plain></SENT>
<SENT sid="5" pm="."><plain>A 1 cm increase in waist circumference increases the risks by 3.2% and 3.5% respectively </plain></SENT>
<SENT sid="6" pm="."><plain>NICE advises using a validated risk assessment tool to identify patients at risk of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Risk factors used by such tools include: age; ethnicity; weight; first-degree relative with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>; <z:hpo ids='HP_0001518'>low birthweight</z:hpo> and sedentary lifestyle </plain></SENT>
<SENT sid="8" pm="."><plain>Certain comorbidities increase the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, these include: cardiovascular and cerebrovascular disease; <z:hpo ids='HP_0000147'>polycystic ovary</z:hpo> syndrome; a history of <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo>; and mental health problems </plain></SENT>
<SENT sid="9" pm="."><plain>The initial screening blood test could be a fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA1c, or an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test, according to WHO criteria </plain></SENT>
<SENT sid="10" pm="."><plain>NICE recommends that high-risk patients should be offered a programme encouraging them to undertake a minimum of 150 minutes of moderate intensity physical activity a week, gradually lose weight to reach and maintain a BMI within the healthy range, increase consumption of whole grains, vegetables, and other foods that are high in dietary fibre, reduce the total amount of fat in their diet and eat less saturated fat </plain></SENT>
</text></document>